Start-up Companies from Single-Cell Lab
Auravax provides a differentiated approach for the generation of Next-Gen vaccines. The company highlights an emphasis on COVID-19, a validated approach, platform technology, and ultimately addressing unmet needs.
CellChorus provides high throughput, dynamic analysis of single cells. The company’s TIMING™ platform applies visual AI to evaluate cell activation, killing and movement as a function of time in order to maximize our understanding of cellular function, state and phenotype.
List of Patents
- Christopher Love, Navin Varadarajan, Boris Juelg and Bruce Walker (2009) “Composition and methods for assessing cytotoxicity of single cells”. PCT/US2009/050411. Granted: US9244071B2
- Navin Varadarajan, Gabrielle Romain, Ivan Liadi, Victor Sendra, and Badrinath Roysam (2015) “Integrated Functional and Molecular Profiling of Immune Cells”. PCT/US2016/024519. Granted: US10746736B2
- Navin Varadarajan and Irfan Bandey (2016) “Enzymatic immunomodulation of tumors”. PCT/US2016/033550. Granted: US10874724B2
- Navin Varadarajan, Richard Willson and Jay R T Adolacion (2016) “Broad spectrum serological diagnostics”. PCT/US2016/033722
- Navin Varadarajan, Gabrielle Romain, Laurence Cooper and Harjeet Singh (2017) “Combination therapy combining CAR+ T cells with appropriately timed immunomodulatory antibodies”. PCT/US2016/048135
- Navin Varadarajan (2017) “Multi-use combined micro and nanowell plates”. PCT/US2016/054737
- Navin Varadarajan, Shaza Abnouf and Ramesh Balakrishnan (2019) “Engineered chymotrypsins and uses thereof”. PCT/US2020/027418
- Navin Varadarajan, Melisa Martinez, Irfan N Bandey, and Harjeet Singh (2019) “Methods of improving the longevity of immune cells”. PCT/US2020/028727
- Navin Varadarajan and Fatemeh Sadeghi (2021) “Salicylic acid-inducible gene expression compositions and systems for cells”. PCT/US2021/60685
- Navin Varadarajan and Xinli Liu (2021) “Treatment and prevention of conditions associated with respiratory diseases”. PCT/US2021/42684
- Navin Varadarajan and Xinli Liu (2021) “Treatment and prevention of conditions associated with respiratory diseases”. PCT/US2021/57825
- Navin Varadarajan and Irfan Bandey (2021) “Methods of use of genetically modified immune cells expressing matrix metallopeptidase 8”. (provisional) US 63/263,818